These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27698251)

  • 1. Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
    Kammerer S; Jahn SW; Winter E; Eidenhammer S; Rezania S; Regitnig P; Pichler M; Schreibmayer W; Bauernhofer T
    J Clin Pathol; 2016 Dec; 69(12):1116-1121. PubMed ID: 27698251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
    Kammerer S; Sokolowski A; Hackl H; Platzer D; Jahn SW; El-Heliebi A; Schwarzenbacher D; Stiegelbauer V; Pichler M; Rezania S; Fiegl H; Peintinger F; Regitnig P; Hoefler G; Schreibmayer W; Bauernhofer T
    Oncotarget; 2016 Dec; 7(51):84705-84717. PubMed ID: 27835900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH.
    Jensen SG; Thomas PE; Christensen IJ; Balslev E; Hansen A; Høgdall E
    APMIS; 2020 Nov; 128(11):573-582. PubMed ID: 32860265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
    Rezania S; Kammerer S; Li C; Steinecker-Frohnwieser B; Gorischek A; DeVaney TT; Verheyen S; Passegger CA; Tabrizi-Wizsy NG; Hackl H; Platzer D; Zarnani AH; Malle E; Jahn SW; Bauernhofer T; Schreibmayer W
    BMC Cancer; 2016 Aug; 16():628. PubMed ID: 27519272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results.
    Oztürk M; Bolkent S; Yilmazer S; Kaner G; Unal H
    Anal Cell Pathol; 1998; 16(4):201-9. PubMed ID: 9762367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene.
    Thomsen C; Nielsen S; Nielsen BS; Pedersen SH; Vyberg M
    Appl Immunohistochem Mol Morphol; 2020; 28(5):347-353. PubMed ID: 30920963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divisional role of quantitative HER2 testing in breast cancer.
    Yamamoto-Ibusuki M; Yamamoto Y; Fu P; Yamamoto S; Fujiwara S; Honda Y; Iyama K; Iwase H
    Breast Cancer; 2015 Mar; 22(2):161-71. PubMed ID: 23604955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
    Wagner V; Stadelmeyer E; Riederer M; Regitnig P; Gorischek A; Devaney T; Schmidt K; Tritthart HA; Hirschberg K; Bauernhofer T; Schreibmayer W
    J Cell Biochem; 2010 Jun; 110(3):598-608. PubMed ID: 20512921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.
    Schmid E; Klotz M; Steiner-Hahn K; Konen T; Frisk AL; Schatz C; Krahn T; von Ahsen O
    Biotech Histochem; 2017; 92(6):425-435. PubMed ID: 28836864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
    Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
    Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
    Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer.
    Stocker A; Trojan A; Elfgen C; Hilbers ML; Moskovszky L; Varga Z
    Breast Cancer Res Treat; 2020 Sep; 183(2):311-319. PubMed ID: 32638236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
    Murawski M; Woźniak M; Duś-Szachniewicz K; Kołodziej P; Rzeszutko M; Ziółkowski P
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
    Hicks DG; Buscaglia B; Goda H; McMahon L; Natori T; Turner B; Soukiazian A; Okada H; Nakano Y
    BMC Cancer; 2018 Dec; 18(1):1266. PubMed ID: 30563489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.
    Pauletti G; Dandekar S; Rong H; Ramos L; Peng H; Seshadri R; Slamon DJ
    J Clin Oncol; 2000 Nov; 18(21):3651-64. PubMed ID: 11054438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 status determination using RNA-ISH--a rapid and simple technique showing high correlation with FISH and IHC in 141 cases of breast cancer.
    Alba J; Gutierrez J; Coupe VM; Fernández B; Vázquez-Boquete Á; Alba J; Forteza J; García-Caballero T
    Histol Histopathol; 2012 Aug; 27(8):1021-7. PubMed ID: 22763874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.